Team:Wageningen UR/Achievements
From 2013.igem.org
Karrenbelt (Talk | contribs) |
Karrenbelt (Talk | contribs) |
||
Line 61: | Line 61: | ||
<h2>Silver medal</h2> | <h2>Silver medal</h2> | ||
<div class="medalcontent"> | <div class="medalcontent"> | ||
- | <p class="yes">Experimentally validate that at least one new BioBrick Part or Device of your own design and construction works as expected</p> | + | <p class="yes">Experimentally validate that at least one new BioBrick Part or Device of your own design and construction works as expected<a href="#" class="info" alt="silverbrick">info</a></p> |
+ | </div> | ||
+ | <div id="silverbrick" class="hiddeninfo"> | ||
+ | <p class="dot"><a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K1023001">The pkiA promoter has successfully been used to express the ATP bio-sensor</a></p> | ||
+ | <p class="dot"><a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K1023002">The xlnD terminator has successfully been used for the ATP bio-sensor</a></p> | ||
+ | <p class="dot"><a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K1023005">the codon optimized eforRed has successfully been used attached to a mitochondrial signal peptide and has given a red color to the mycellium of <i>Aspergillus niger</i></a></p> | ||
+ | <p class="dot"><a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K1023006">Even though the Actin-GFP fusion did work very well within <i>Aspergillus niger</i> due to an illegal restriction site we were not able to submit it.</a></p> | ||
+ | </div> | ||
+ | <div class="medalcontent"> | ||
<p class="yes">Document the characterization of this part in the “Main Page” section of that Part’s/Device’s Registry entry</p> | <p class="yes">Document the characterization of this part in the “Main Page” section of that Part’s/Device’s Registry entry</p> | ||
<p class="yes">Submit this new part to the iGEM Parts Registry</p> | <p class="yes">Submit this new part to the iGEM Parts Registry</p> |
Revision as of 01:15, 5 October 2013
- Achievements
- Attributions
- Safety introduction
- General safety
- Fungi-related safety
- Biosafety Regulation
- Safety Improvement Suggestions
- Safety of the Application
Achievements
- Achievements
- Attributions
Bronze medal
Team registration
Complete Judging form
Team Wiki
Present a poster and a talk at the iGEM Jamboree
Document at least one new standard BioBrick Part or Device used in your project/central to your project and submit this part to the iGEM Registryinfo
The pkiA promoter is a constitutive promoter used for Aspergillus niger.
The xlnD terminator is a terminator used for Aspergillus niger.
A codon optimized ATP bio-sensor used in Aspergillus niger.
A codon optimized pH bio-sensor used in Aspergillus niger
A codon optimized eforRed chromoprotein for use in Aspergillus niger
A ketosynthase domain part of a polyketide synthase (lovB) optimized for Aspergillus niger
Silver medal
Experimentally validate that at least one new BioBrick Part or Device of your own design and construction works as expectedinfo
The pkiA promoter has successfully been used to express the ATP bio-sensor
The xlnD terminator has successfully been used for the ATP bio-sensor
Document the characterization of this part in the “Main Page” section of that Part’s/Device’s Registry entry
Submit this new part to the iGEM Parts Registry
Your project may have implications for the environment, security, safety and ethics and/or ownership and sharing. Describe one or more ways in which these or other broader implications have been taken into consideration in the design and execution of your project
Gold medal
Improve the function of an existing BioBrick Part or Device, enter this information in the Registry, create a new registry page for the improved part, and submit this part to the iGEM Parts Registry
Help any registered iGEM team from another school or institution by, for example, characterizing a part, debugging a construct, or modeling or simulating their system
Your project may have implications for the environment, security, safety and ethics and/or ownership and sharing. Describe a novel approach that your team has used to help you and others consider these aspects of the design and outcomes of synthetic biology efforts. Please justify its novelty and how this approach might be adapted and scaled for others to use